
Sign up to save your podcasts
Or


Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.2
526526 ratings
Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,085 Listeners

1,355 Listeners

240 Listeners

154 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

326 Listeners

67 Listeners

154 Listeners

294 Listeners

33 Listeners

45 Listeners

2,149 Listeners

1,302 Listeners

586 Listeners

5 Listeners

20 Listeners

1,561 Listeners

213 Listeners

410 Listeners

300 Listeners

119 Listeners

825 Listeners

171 Listeners

34 Listeners

10 Listeners

29 Listeners

9 Listeners

16 Listeners

2 Listeners